---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-256103"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:06:36.533362+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Mirum files updated risk factor disclosure; no financial or operational news

## Summary
- Update includes risks related to sole-source contract manufacturers for commercial supplies.
- Lists risk of needing additional financing for commercialization and product development.
- Notes potential delays in patient enrollment and clinical trial completion.
- References the Asset Purchase and risk of not realizing its anticipated benefits.

## SEC filing metadata
- accession: 0001193125-23-256103
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/0001193125-23-256103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000119312523256103/d424554d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-256103
- JSON: https://secwatch.observer/filing/0001193125-23-256103.json
- Plain text: https://secwatch.observer/filing/0001193125-23-256103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.